Having dealt with the DC bureaucracy and mindset, I have a feeling that the FDA wants to see the protocols for CD 16 and maybe CD 17 before the provisional EUA is granted. Since the EUA would be conditioned on Cytodyn doing the trials, it is DC logical to want proof Cytodyn is proceeding. I am not saying that FDA should wait, just that it fits their MO. (If this has been mentioned before, sorry for redundancy.)